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Abstract
Background: The gold standard for the diagnosis of cholera is stool culture, but this requires laboratory facilities and takes
at least 24 hours. A rapid diagnostic test (RDT) that can be used by minimally trained staff at treatment centers could
potentially improve the reporting and management of cholera outbreaks.
Methods: We evaluated the Crystal VCTM RDT under field conditions in Zanzibar in 2009. Patients presenting to treatment
centers with watery diarrhea provided a stool sample for rapid diagnostic testing. Results were compared to stool culture
performed in a reference laboratory. We assessed the overall performance of the RDT and evaluated whether previous
intake of antibiotics, intravenous fluids, location of testing, and skill level of the technician affected the RDT results.
Results: We included stool samples from 624 patients. Compared to culture, the overall sensitivity of the RDT was 93.1%
(95%CI: 88.7 to 96.2%), specificity was 49.2% (95%CI: 44.3 to 54.1%), the positive predictive value was 47.0% (95%CI: 42.1 to
52.0%) and the negative predictive value was 93.6% (95%CI: 89.6 to 96.5%). The overall false positivity rate was 50.8% (213/
419); fieldworkers frequently misread very faint test lines as positive.
Conclusion: The observed sensitivity of the Crystal VC RDT evaluated was similar compared to earlier versions, while
specificity was poorer. The current version of the RDT could potentially be used as a screening tool in the field. Because of
the high proportion of false positive results when field workers test stool specimens, positive results will need to be
confirmed with stool culture.
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Introduction
Cholera remains a very common and potentially lethal disease
in Asia and Africa. Globally, more than 220,000 cases were
reported to the World Health Organization (WHO) in 2009 [1],
however the true number of cases, including unreported cases, is
likely to be much higher – perhaps 3–5 million cases/year [2].
Cholera occurs mainly in areas with poor infrastructure and
limited access to clean water. The etiologic organisms, Vibrio
cholerae O1 and O139, are highly transmissible and can cause
explosive outbreaks. While many of those affected experience only
mild symptoms, some suffer from severe disease characterized by
profuse diarrhea, electrolyte imbalance, coma and death if prompt
rehydration is not provided [3,4]. Cholera cases have been
reported from Zanzibar since 1978 with regular outbreaks
documented since then [5,6].
The gold standard for laboratory confirmation of cholera is
stool culture [7]. This is a routine procedure but requires
laboratory infrastructure including trained staff. A single stool
culture costs approximately 4 USD/case [8] and requires about 24
to 72 hours and transport to the closest sufficiently equipped
laboratory, which may create additional costs. Furthermore,
microbiologic facilities are often not available in locations where
cholera occurs. A rapid diagnostic test (RDT) that is simple, easy
to use and interpret, can be stored without refrigeration and is
reasonably priced so that it can be deployed widely would be
useful for the early confirmation of cholera outbreaks. Ideally, the
RDT should be highly sensitive so as not to miss the diagnosis of
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cases and be sufficiently specific when used under actual field
conditions [9]. Cholera confirmation would enable immediate
implementation of control measures such as reactive vaccination
[6], as well as more accurate reporting of the burden of the disease.
A cholera RDT based on the detection of lipopolysaccharide
(LPS) using gold particles was developed by the Institute Pasteur
(IP). The RDT is a lateral flow immunochromatographic test for
the qualitative determination of lipopolysaccharide antigen of both
Vibrio cholerae O1 and O139 serogroups from stool specimens using
monoclonal antibodies specific to V. cholerae O1 and O139 LPS.
Through a licensure agreement, the RDT is now being produced
by Span Diagnostics (Surat, India) under the trade name Crystal
VCTM at a price of 19.00 USD/test kit (10 test strips). The test kit
is stable at temperatures between 4uC to 30uC, and test strips are
packed in waterproof pouches, allowing storage under high
humidity conditions. Previous evaluations have been performed
on the prototype and commercial versions of the RDT [10–15].
The primary objective of this study is to validate the current
version of the Crystal VCTM RDT when performed by health
workers in first-level treatment centers in Zanzibar. We also sought
to assess if the RDT results were affected by the skill level of the
reader and previous intake of antibiotics or intravenous fluids.
Methods
Ethics
The study was conducted according to the principles expressed
in the Declaration of Helsinki. Written informed consent was
obtained from all participants. The Zanzibar Research Council
Ethics Committee, the Institutional Review Board of the
International Vaccine Institute, Seoul, Korea, and the Research
Ethics Review Committee of the World Health Organization,
Geneva, Switzerland approved this project.
Study site
The archipelago of Zanzibar lies about 50 kilometers east of
mainland Tanzania and consists of two main islands, Unguja and
Pemba, as well as smaller islets (Figure 1). In 2009, Zanzibar had a
population of about 1.22 million [16]. Stool samples were collected
at cholera treatment camps that were set up during outbreaks on
the two main islands, Unguja and Pemba, in 2009. Treatment of
patients was provided according to national guidelines.
Study procedures
Acute watery diarrhea was defined as a minimum of three
liquid, non-bloody, stools within 24 hours. Prior to presentation,
no further inclusion/exclusion criteria were applied. Patients
presenting with acute watery diarrhea were requested to provide a
stool sample in a disposable plastic container. A swab was inserted
into the stool sample and used to inoculate a tube of pre-packaged
Cary Blair medium (EIKEN, Japan) for transport to the
laboratory. About 200 ml of stool from each sample was used for
dipstick testing on site. A case report form (CRF) was completed to
record frequency of bowel movement over the previous 24 hours,
antibiotics received, and fluid management (intravenous (IV) or
oral rehydration solution (ORS)) provided at the health center.
Bulk stool from a subset of patients attending a camp close to one
of the participating laboratories was transported to the lab for
additional testing on the same day as described below.
Dipstick test. The RDT was stored at room temperature and
performed according to the package insert. Liquid stool was
collected in a disposable plastic container. Approximately 200 ml
(4 drops) of stool were transferred with a disposable pipette to a
disposable test tube provided with the kit. One drop of dilution
buffer was added. The dipstick was inserted into the diluted stool
and results were read within 15–20 minutes. The appearance of
two bands on the dipstick, one control and one test, indicated that
the stool sample was positive for V. cholerae. The appearance of only
the control band indicated a negative sample. The non-appear-
ance of the control band indicated a procedural error. Stool
samples were tested under field conditions in the cholera treatment
centers and in the laboratory as described below. Dipstick results
were recorded on the CRF, whereas laboratory results were
recorded in separate laboratory forms.
a. Performed under field conditions. A local health worker in
each cholera treatment camp performed the RDT after
training and a copy of the English test kit manual containing
illustrations on test procedure and interpretation had been
provided. Training consisted of a theoretical session using a
Power Point Presentation containing information on test
procedures and schematic pictures of positive and negative
test results based on the package insert. This was followed by a
practical session during which the test was performed a
number of times. All field workers where visited frequently in
the field to ensure correct handling of the test. All local health
workers had completed at least primary education and
delivered basic medical services to attending diarrheal
patients. Fieldworkers performed the test outdoors in daylight.
b. Performed under laboratory conditions. In order to assess the
potential influence of environmental and light conditions,
laboratory technicians were asked to repeat the test on bulk
stool collected at the camps and to read the result
independently. Stool culture results were not yet available at
the time of the performance of the test and laboratory
technicians were blinded as to the results of the RDT
performed in the field, as well as the clinical picture of the
patient. Two laboratory technicians performed the RDT after
receiving training similar to the field workers and had received
a copy of the test kit manual. The laboratory technicians
performed the test indoors using electric light sources. All
participating technicians had a diploma in laboratory sciences,
which requires a minimum of one year of education, and had
a minimum of three years working experience.
Stool culture. Upon arrival in the laboratory, samples from the
Cary Blair media were streaked out on Thiosulphate Citrate Bile
Sucrose Agar (TCBS; EIKEN, Japan), inoculated in alkaline
peptone water (APW) and incubated at 37uC for 12–24 hours. If
samples arrived as bulk stool, the samples were diluted in APW.
An aliquot was streaked out on TCBS and the samples in APW
and on TCBS were incubated for 12–24 hours at 37uC. If no
growth on TCBS was detected after incubation, an aliquot of the
sample in APW was streaked out on TCBS and incubated again. If
yellow colonies indicative of V. cholerae were detected on TCBS,
motility indole ornithine agar (MIO) and triple sugar iron agar
(TSI) were inoculated with colonies from TCBS and incubated for
18 hours at 37uC. In addition, a colony from TCBS was sub-
cultivated on gelatin agar for later serological confirmation and
incubated at 37uC overnight. If colonies indicative of V. cholerae
were observed on TSI and MIO after incubation, colonies from
gelatin agar were tested for agglutination reactions with O1
polyvalent, O1 Inaba, O1 Ogawa and O139 antiserum (Beckton
Dickinson, USA) as described elsewhere [17]. V. cholerae strains were
transported to the National Institute of Cholera and Enteric
Diseases in Kolkata, India where identification of the isolates was
confirmed.
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Definitions, data management and analysis
The CRF and laboratory results of each patient were
computerized and linked using unique study identification
numbers. The primary endpoint was the assessment of the
performance of the RDT (done in the field) using microbiological
stool culture result as the gold standard for comparison. Sensitivity
(true-positive or TP rate) was defined as the probability that
patients with laboratory-confirmed cholera had a positive RDT.
Specificity (true-negative or TN rate) was the probability that
patients with no laboratory-confirmed cholera had a negative
RDT. The positive predictive value (PPV) was the probability that
patients with a positive RDT had V.cholerae isolated from stool
culture. The negative predictive value (NPV) was the probability
that patients with a negative RDT had no V.cholerae isolated from a
stool culture. The false positivity or FP rate ( = FP/[FP+TN] or
12specificity) was the proportion of stool samples with no V.
cholerae isolated on culture but showed a positive RDT result. The
false negativity or FN rate ( = FN/[TP+FN] or 12sensitivity) was
the proportion of stool samples with V. cholerae isolated on culture
but showed a negative RDT result.
We performed sub-group analyses by island (Pemba or Unguja),
by previous recent intake versus non-intake of antibiotics and by
receipt of intravenous fluids following previously published studies
showing differences in RDT performance [13]. We defined recent
intake of antibiotics as receipt of any oral or parenteral
antimicrobial for the current illness prior to the collection of a
stool sample. We classified fluid management at the treatment
center as oral rehydration solution (ORS) or intravenous fluids
(IVF) with or without ORS. To assess whether test validity was
related to skill level of the reader and location of the testing, we
compared the performance of the RDT when done in the field
versus in the laboratory on a subset of samples.
Comparison of unpaired samples was done using chi-square
test; comparison of paired samples was done using McNemars test.
Confidence intervals were calculated using exact method. Level of
agreement was calculated using Cohen’s Kappa test for unweight-
ed proportions. Calculations were done using Stata, version 10
(StataCorp, College Station, TX, USA). Performance indicators
were calculated using Excel 2010 (Microsoft, WA, USA).
Results
There were 624 patients who presented to a cholera treatment
camp with acute watery diarrhea and were recruited into the
study: 81 in Unguja and 543 in Pemba. We excluded 2 samples
sent for culture but on which no RDT was done. A total of 622
stool samples were included in the analysis, 79 (13%) from Unguja
and 543 (87%) from Pemba residents (Figure 2).
Performance of the RDT in the field
Of the 622 stool samples, 203 (32.6%) yielded V. cholerae O1. No
V. cholerae O139 was isolated. Using culture results as the gold
standard, we calculated the sensitivity, specificity, PPV, and NPV
of the RDT performed in the field for the diagnosis of cholera
(Table 1). Overall sensitivity was 93.1% (95%CI: 88.7 to 96.2%),
specificity was 49.2% (95%CI: 44.3 to 54.1%), the positive
predictive value (PPV) was 47.0% (95%CI: 42.1 to 52.0%) and the
negative predictive value (NPV) was 93.6% (95%CI: 89.6 to
96.5%). The overall false positivity rate was 50.8% (213/419).
Sub-group analyses of performance of the RDT in the
field
We evaluated the RDT performance by island (Table 1). V.
cholerae was isolated from 46/79 or 58.2% of stool samples from
Unguja compared to a significantly lower proportion of 157/543
or 28.9%, from Pemba (p,0.01). No significant differences in
sensitivity, specificity and NPV of the RDT were observed
between Unguja and Pemba, as well as between each island with
the overall results (all p.0.05). However, we found a significant
difference in PPV between Unguja and Pemba (71.9, 95%CI:
58.5–83.0 versus 42.9, 95%CI: 37.6–48.3; p = 0.02).
We compared the RDT performance by fluid management of
patients: Rehydration treatment at the cholera camp was recorded
for 592/622 (95.2%) participants (Table 2). Only 15.2% (32/210)
of participants who received oral rehydration had a positive stool
Figure 1. Study site.
doi:10.1371/journal.pone.0036930.g001
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Figure 2. Flow of study participants.
doi:10.1371/journal.pone.0036930.g002
Table 1. Performance of the cholera rapid diagnostic test, Pemba and Unguja, Zanzibar.
Sensitivity% (95%CI*)
(TP/(TP+FN))
Specificity% (95%CI*)
(TN/(TN+FP))
PPV% (95%CI*) (TP/
(TP+FP))
NPV% (95%CI*) (TN/
(TN+FN))
No. pos./total (%)
with V. cholera
isolated on stool
culture
Total (n =622) 93.1 (88.7–96.2) (189/203) 49.2 (44.3–54.1) (206/419) 47.0 (42.1–52.0) (189/402) 93.6 (89.6–96.5) (206/220) 203/622 (32.6)
Unguja (n=79) 89.1 (76.4–96.4) (41/46) 51.5 (33.5–69.2) (17/33) 71.9 (58.5–83.0) (41/57) 77.3 (54.6–92.2) (17/22) 46/79 (58.2)
Pemba (n=543) 94.3 (89.4–97.4) (148/157) 49.0 (43.9–54.1) (189/386) 42.9 (37.6–48.3) (148/345) 95.5 (91.5–97.9) (189/198) 157/543 (28.9)
p 0.82 0.87 0.02 0.53 ,0.01
*using exact method.
doi:10.1371/journal.pone.0036930.t001
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culture, compared with 43.2% (165/382) of those who received IV
fluids (p,0.01). There were no statistically significant differences
in sensitivity, specificity and NPV of RDT performance by fluids
received (all p.0.05). However we again found a significant
difference in PPV among those who received oral compared to IV
rehydration (26.8%, 95%CI: 18.9 to 36.0% versus 55.2%, 95%CI:
49.2 to 61.2%; p,0.01). To evaluate whether the provided fluid
treatment biased the field workers’ interpretation of the RDT
results, we compared the false positivity rate by fluid management.
The false positivity rate was 46.1% among those who were orally
rehydrated and 57.1% among those who were intravenously
rehydrated (p = 0.22).
Information on prior antibiotic treatment was recorded for 576/
622 (92.6%) participants. The percentage with a positive stool
culture was 27.6% among those who had received antibiotics and
32.2% among those who had not (p = 0.60). We assessed whether
previous antibiotic treatment affected the RDT performance
(Table 2). Sensitivity, specificity, PPV and NPV did not vary
significantly among recipients and non-recipients of antibiotics.
The false positivity rate was 40.5% among those who had received
antibiotics and 50.7% among those who had not (p = 0.45).
Comparison of the performance of the RDT in the field
versus in the laboratory
We compared the performance of RDT on a subset of 67/79
(84.8%) stool samples from Unguja tested both in the field and in
the laboratory (Table 3). In this subset, 40/67 (59.7%) samples
yielded V. cholerae on culture. There was no statistically significant
difference in the sensitivity, specificity PPV and NPV of the RDT’s
performance (all p.0.05). The false positivity rate of the RDT was
45.4% in the field and 25.9% in the laboratory (Cohen’s kappa
0.8).
Operational characteristics
The test procedure, excluding sample collection, requires 20–
25 minutes. The test kit manual provides clear instructions, and
handling of the test was considered simple by field workers. Field
workers found it easy to distinguish between valid and non-valid
test results, based on the appearance of a control line. However,
very faint positive test lines were interpreted as a positive result,
but could not be confirmed by culture.
Discussion
We found an overall high sensitivity (93.1%) of the current
version of the cholera RDT consistent with previous reports but a
much poorer specificity (49.2%). Earlier studies were performed
using a prototype dipstick – developed by the Institute Pasteur –
and earlier versions of the commercial kit. Studies using the
prototype versions of the RDT reported sensitivities in the range of
93% to 99% and specificities of 67%–97% [12–15]], whereas
more recent reports on earlier versions of the commercial kit
Table 2. Stratified analysis of the performance of cholera dipstick test according to fluid management (oral rehydration or
intravenous fluids) in 592 patients and recent antibiotic intake (yes or no) in 576 patients.
Sensitivity (95%CI)*
(TP/(TP+FN))
Specificity (95%CI)*
(TN/(TN+FP))
PPV (95%CI)* (TP/
(TP+FP))
NPV (95%CI)* (TN/
(TN+FN))
No. pos./total (%)
with V. cholerae
isolated on stool
culture
Fluid management (n =592)
Oral rehydration n=210 93.8 (79.2–99.2) (30/32) 53.9 (46.3–61.4) (96/178) 26.8 (18.9–36.0) (30/112) 98.0 (92.8–99.8) (96/98) 32**/210 (15.2)
Intravenous
rehydrationn=382
92.7 (87.6–96.1) (153/165) 42.9 (36.2–49.7) (93/217) 55.2 (49.2–61.2) (153/277) 88.6 (80.9–94.0) (93/105) 165**/382 (43.2)
p 0.97 0.19 ,0.01 0.62 ,0.01
Recent antibiotic (AB) intake (n=576)
AB received n=58 93.8 (69.7–99.8) (15/16) 59.5 (43.3–74.4) (25/42) 46.9 (29.1–65.3) (15/32) 96.2 (80.4–99.9) (25/26) 16/58 (27.6)
No AB received n=519 92.8 (87.8–96.2) (155/167) 49.3 (43.9–54.7) (173/351) 46.5 (41.1–52.1) (155/333) 93.5 (86.1–94.7) (173/190) 167/518 (32.2)
p 0.98 0.48 0.98 0.86 0.60
*using exact method.
**in 6/203 culture positive cases no rehydration treatment was provided.
doi:10.1371/journal.pone.0036930.t002
Table 3. Comparison of the field and laboratory performance of the cholera dipstick test.
(n = 67)
Sensitivity% (95%CI*)
(TP/TP+FN)
Specificity% (95%CI*)
(TN/TN+FP)
PPV% (95%CI*) (TP/
TP+FP)
NPV% (95%CI*) (TN/
TN+FN)
No. (%) with V. cholera
isolated on stool
culture**
Field 90.0 (76.3–97.2) (36/40) 55.6 (35.3–74.5) (15/27) 75.0 (60.4–86.4) (36/48) 78.9 (54.4–93.9) (15/19) 40 (59.7)
Laboratory 87.5 (73.2–95.8) (35/40) 74.1 (53.7–88.9) (20/27) 83.3 (68.6–93.0) (35/42) 80.0 (59.3–93.2) (20/25) 40 (59.7)
P*** 0.931 0.510 0.740 0.977
*using exact method.
**rapid diagnostic testing was done both in the field and in the laboratory on specimens from the same stool samples.
***using McNemars test.
doi:10.1371/journal.pone.0036930.t003
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showed sensitivities of 92–97% and specificities of 71–76%
[10,11]. These studies not only varied by the RDT version used
but also by the methodology and qualifications of the study
personnel performing the RDT (Table 4). There were also
variations in the test procedure such as addition or non-addition of
a buffer solution to the sample. In some studies, a 4-hour
incubation step in alkaline peptone water was added. Overall, the
prototype and precursor commercial kits performed better than
the current version tested.
The poor specificity of the current version of the commercial kit
was associated with an overall false positive rate of 50.8%. The
RDT’s false positivity rate when the RDT was read in the field was
44% versus 26% when done by laboratory technicians; possibly
faint test lines on the dipsticks were over-read by field workers as
positive. We hypothesized whether patient characteristics (fluid
management or receipt of antibiotics) biased the field workers’
interpretation of the RDT results. However, we found no
significant differences in false positivity in these sub-group
analyses. More likely the fieldworkers over-interpreted faint test
lines which could be recognized in daylight but not in the indoor
laboratory setting.
Previously, Kalluri et al. assessed the impact of the reader’s
qualification on the performance of the prototype test [12].
Laboratory technicians with several years of working experience as
well as field workers with at least a college degree but no
laboratory experience were asked to perform the test on 304 stool
samples. The reported RDT sensitivities of 94% and 93% when
done by laboratory technicians and field workers, respectively,
were similar, but RDT specificity was higher when performed by
the technicians (76% versus 67%) [12]. Harris et al. report a
sensitivity of 97% and a specificity of 71–76%, when staff with
graduate-level laboratory training performed the test in Guinea
Bissau [10]. Mukherjee et al. reported a similar sensitivity and
specificity (92% and 73%, respectively) when the test was done by
graduate-level staff during a surveillance study at a hospital in
Kolkata [11].
In contrast to Wang et al., we did not find a higher sensitivity of
the RDT when testing stool samples from patients receiving IVF
compared to samples from patients who did not receive IVF [13].
However, we noted that the PPV in this study varied according to
the proportion of culture-positive specimens. It has been argued
that PPV is the most important measure of a clinical diagnostic
method since it represents the proportion of patients with positive
test results that are correctly diagnosed [18]. The PPV is not
intrinsic to the test; it is affected by prevalence of the disease. For
example, the PPV was 55% for samples from patients given IVF
(43% of whom had V. cholerae isolated) while it was 27% for
samples from patients managed with ORS (15% of whom had V.
cholerae isolated). The PPV was 71.9% for the Unguja sub-sample
with 58% cholera confirmation while for the Pemba sub-sample it
was 43% with 29% cholera confirmation. In outbreak settings,
when a large proportion of patients presenting with acute watery
diarrhea have cholera, a positive RDT result would have a good
predictive value. In other situations (e.g. areas with seasonal
cholera but also high rates of diarrheal diseases from other
pathogens), the RDT may be less useful.
Our study has several limitations. Firstly, a large sample from
622 study participants was available for the overall evaluation, but
only 67 stool samples were used for sub-analyses. Secondly, while
confirmation of V. cholerae isolates was performed at a reference
laboratory, culture-negative stool samples were not validated
further. In particular, we did not perform PCR testing on our
RDT-positive, culture-negative samples. Bhuiyan, et al. [14]
analyzed five stool samples collected in Bangladesh by multiplex
PCR that were O1 dipstick positive but culture-negative and
found that all five were negative by PCR, indicating that the five
dipstick-positive results were false positives. This is reassuring but
does not entirely exclude the possibility of false negativity by stool
culture. Thirdly, Alam et al. pointed out that the dipstick may
detect non-culturable forms of V. cholerae that have transformed
into a coccoid form due to unfavorable intra-host conditions, such
as antibiotic treatment prior to testing [7]. We tried to assess the
influence antibiotic treatment prior to sample collection may have
had on our results but found no significant difference (p.0.05) in
the false positive rates among participants who had taken
antibiotics prior to sample collection and those who had not.
However, further research is needed to rule out the possibility that
the RDT may detect V. cholerae antigen in some specimens which
are culture negative.
Conclusion
We found that field workers in this study who had basic general
education but were not familiar with laboratory work experienced
difficulties in interpreting the RDT performed in the cholera
camps. If the RDT is to be deployed more widely, more extensive
and repeated training may be required to improve the current
RDT’s specificity. The test cannot replace stool culture and due to
the high number of false positive results observed is not suitable to
trigger an outbreak response in a resource poor setting. However
the test may be potentially used as a screening tool. During cholera
outbreaks, especially when several samples test positive, the test
has an enhanced predictive value. Further research is needed to
evaluate the accuracy of the RDT with specimens which have
been incubated in APW for 4 to 6 hours prior to testing in the
RDT since this procedure should dilute out the materials in stool
samples which are causing the false positive results while
amplifying the antigen signal from the V. cholerae.
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